Prourocare Medical Inc. (PUMD)
EXPM EXPM Primary Summary
Prourocare Medical Inc. (PUMD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Prourocare Medical Inc. ever had a stock split?
Prourocare Medical Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Benjamin Banks CEO | EXPM Exchange | 74373C206 CUSIP |
| US Country | 2 Employees | - Last Dividend | 14 Feb 2008 Last Split | - IPO Date |
Overview
ProUroCare Medical Inc. is a company focused on the development and commercialization of advanced diagnostic products specifically designed for the detection and characterization of prostate disease in men. Established in 1999 and headquartered in Eden Prairie, Minnesota, the company collaborates closely with Artann Laboratories Inc. through licensing, development, and commercialization agreements to bring innovative solutions to the healthcare market. Their flagship offering, the ProUroScan System, represents a significant advancement in prostate health management, enabling physicians to better document and analyze prostate abnormalities previously identified through traditional examination methods.
Products and Services
- ProUroScan System
The ProUroScan System stands out as ProUroCare Medical Inc.'s premier product, designed to enhance the diagnostic capabilities in the management of prostate health. Utilizing state-of-the-art imaging technology, this system offers a new level of diagnostic support following initial detection of abnormalities through a digital rectal exam (DRE). The ProUroScan System assists healthcare providers by visually documenting and mapping prostate abnormalities, promoting a more informed and precise approach to prostate disease characterization and management.
